Drug and biomedical firms, medical supply and device manufacturers, and group purchasing organizations would be required to report payments or other transfers of value made to physicians and teaching hospitals under a new rule. The information would be made publicly available by Sept. 30, 2013.

The Centers for Medicare and Medicaid Services will publish the proposed rule in the Federal Register on Dec. 19. The rule is intended to reduce potential conflicts of interest that may result from provider relationships with manufacturers, according to CMS. The rule is authorized under the Affordable Care Act.

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access